Human-induced pluripotent stem cell technology for the establishment of a versatile pancreatic ductal disease platform

Nowadays, a biotechnological game changer in regenerative medicine and regenerative pharmacology is indisputably induced pluripotent stem cell technology. Particularly, human-induced pluripotent stem cells (hiPSCs) construct the basis of various functional models in both health and disease states. U...

Descrición completa

Detalles Bibliográficos

Autor Principal:	S. Simsek
Formato:	Artigo
Idioma:	Inglês
Publicado:	Verduci Editore 2021-03-01
Series:	CellR4
Assuntos:	directed differentiation drug discovery ductal disorders of the exocrine pancreas hescs hipscs induced pluripotent stem cells organ-on-a-chip pancreatic ductal diseases personalized medicine reprogramming
Acceso en liña:	https://www.cellr4.org/wp-content/uploads/sites/2/2021/03/e3086.pdf
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!